Future-Proofing Clinical Trials: How Sponsors Can Up-Scale Through Automation

As clinical trials become more complex and global, ensuring temperature integrity across the supply chain has become a significant bottleneck. Based on our experience working with major pharmaceutical companies, we’ve identified three primary pain points:

• 1. Increased Complexity & Site Burden
  Clinical trials are expanding in scale, requiring faster execution while placing additional pressure on clinical sites to maintain strict temperature monitoring.
• 2. Manual & Reactive Processes
  Many sponsors still rely on outdated manual calculations and spreadsheets for temperature data, leading to inefficiencies and compliance risks.
• 3. Lack of Real-Time Visibility
  Without digital integration, sponsors lack a clear view of temperature deviations across the supply chain, causing delays in decision-making and potential risks to patient safety.

The Power of Automation, From Days to Seconds

During the session, Anita engaged the audience with live poll questions, revealing that the majority of attendees struggle with real-time visibility and manual processes. This confirms what we see across the industry, that many sponsors need smarter, automated solutions to stay compliant and efficient.

By leveraging automated temperature monitoring, our pharmaceutical clients have reported significant improvements, including:

• Instant release decisions enabled with 94.9% of temperature excursions resolved automatically, avoiding unnecessary quarantine time.
• Accelerated drug availability when more than 100,000 clinical kits, though affected by excursions, were cleared for use without delays, ensuring that critical medications reach patients on time.
• Sponsor cost savings exceeding $5M annually with reduced excursion evaluation time, lower inventory holding costs, and improved resupply efficiency.

Where Does Your Organization Stand in the Digital Maturity Journey?

Not all sponsors are at the same stage of digital transformation. Some organizations still operate in silos, where manual data handling and slow deviation resolution create inefficiencies. Without proper integration within the technological infrastructure, teams often struggle to maintain visibility, leading to delays and compliance risks.

Others have started to integrate digital tools and IoT, but still rely on manual reviews, limiting the speed and efficiency of their processes. While small improvements have been made, they are not enough to keep up with the growing complexity of clinical trials.

The most advanced sponsors have fully automated and integrated temperature monitoring systems in their end-to-end trial supply process. Some of these organizations also leverage predictive analytics to prevent excursions before they happen, ensuring faster, more efficient decision-making and improved compliance across the entire trial process.

‍

‍

Real-World Success by Leading Pharma Companies

Some of the largest pharma companies world-wide have already embraced automation with remarkable results. Some sponsors have successfully onboarded hundreds of studies to automated temperature monitoring, significantly reducing clinical site workload and minimizing excursion risks. By streamlining and automating the excursion the evaluation process, these organizations have been able to release investigational drugs more quickly, ensuring that critical treatments are readily available to patients.

‍

With 94.9% of temperature excursions instantly resolved, we’ve seen a dramatic reduction in quarantine times, ensuring faster drug availability for patients.

‍

In addition to improving efficiency, some of our customers have also implemented real-time storage monitoring across thousands of clinical sites. This has led to higher data accuracy, better visibility into trial performance, and a proactive approach to temperature management. By integrating real-time insights, sponsors can swiftly address potential risks, reducing the likelihood of temperature excursions impacting drug availability.

These results demonstrate the tangible benefits of automation in clinical trial supply chains. By eliminating manual processes and leveraging data-driven decision-making, sponsors are achieving substantial time and cost savings while ensuring compliance and patient safety.

Is Your Clinical Trial Future-Proof?

Sponsors who embrace automation can scale operations, minimize risks, and optimize compliance. Here’s a quick check-list to evaluate your current status:

• A. Do we have full visibility across the entire kit lifetime?
• B. Are our systems integrated for seamless performance?
• C. Are we leveraging real-time data for predictive forecasting?

If your organization still relies on manual processes, now is the time to take the next step toward automation. Consult our experts at TSS today, and we will support you in every stage of your digital transformation journey.